SBC Medical Group (NASDAQ:SBC) Hits New 12-Month High – Still a Buy?

Shares of SBC Medical Group Holdings Incorporated (NASDAQ:SBC) hit a new 52-week high during mid-day trading on Monday . The company traded as high as $5.09 and last traded at $5.0270, with a volume of 47270 shares traded. The stock had previously closed at $4.75.

Wall Street Analyst Weigh In

Several research firms have weighed in on SBC. BTIG Research reiterated a “buy” rating and set a $8.00 price target on shares of SBC Medical Group in a research note on Thursday, August 13th. Weiss Ratings reaffirmed a “sell (d+)” rating on shares of SBC Medical Group in a report on Wednesday, August 19th. Finally, Wall Street Zen upgraded SBC Medical Group from a “buy” rating to a “strong-buy” rating in a research report on Saturday. Two research analysts have rated the stock with a Buy rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average price target of $8.50.

SBC Medical Group Trading Down 1.9%

The stock has a market cap of $518.36 million, a PE ratio of 10.72 and a beta of 0.63. The company’s fifty day moving average is $3.74 and its 200-day moving average is $3.55. The company has a debt-to-equity ratio of 0.09, a current ratio of 3.31 and a quick ratio of 3.27.

SBC Medical Group (NASDAQ:SBC) last released its quarterly earnings data on Thursday, August 13th. The company reported $0.10 EPS for the quarter, missing the consensus estimate of $0.12 by ($0.02). SBC Medical Group had a return on equity of 18.47% and a net margin of 27.99%.The company had revenue of $49.19 million during the quarter, compared to analysts’ expectations of $45.37 million. On average, analysts predict that SBC Medical Group Holdings Incorporated will post 0.44 earnings per share for the current fiscal year.

Institutional Trading of SBC Medical Group

Several institutional investors have recently bought and sold shares of SBC. Bank of America Corp DE acquired a new stake in SBC Medical Group in the 2nd quarter worth about $35,000. Bank of New York Mellon Corp acquired a new position in shares of SBC Medical Group during the first quarter valued at approximately $43,000. Williams & Novak LLC raised its holdings in shares of SBC Medical Group by 31.2% during the second quarter. Williams & Novak LLC now owns 18,686 shares of the company’s stock valued at $58,000 after acquiring an additional 4,449 shares during the last quarter. Deutsche Bank AG purchased a new position in shares of SBC Medical Group in the second quarter valued at approximately $58,000. Finally, Two Sigma Securities LLC purchased a new position in shares of SBC Medical Group in the second quarter valued at approximately $66,000. 60.82% of the stock is owned by institutional investors and hedge funds.

SBC Medical Group Company Profile

SBC Medical Group (NASDAQ: SBC) is a Japan-based medical services and management company focused primarily on the aesthetic medicine sector. Through its affiliated medical corporations and clinic network, the company supports the operation of facilities offering cosmetic surgery, cosmetic dermatology and related elective treatments.

The company provides a range of management and operational services to affiliated clinics, including branding and marketing, staff recruitment and training, purchasing, information technology, administrative support and business consulting.